EcoNaviSta

News

Eisai's bid to develop an integrated care platform for dementia in Japan has moved forward with the acquisition of remote monitoring firm EcoNaviSta.

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.